Real-time enrollment status for this metastatic melanoma clinical trial
Current Status
Recruiting
Checked: October 13, 2026 at 12:04 PM UTC
| NCT Number | NCT05155033 |
| Recruiting Status | Recruiting |
| Condition | Metastatic Melanoma |
| Phase | PHASE2 |
| Target Enrollment | 78 participants |
| Active Locations | 1 sites in the US |
| Sponsor | National Cancer Institute (NCI) |
| Last Updated on CT.gov | October 8, 2026 (5 days ago) |
As of October 13, 2026: Clinical trial NCT05155033 is currently recruiting participants. This phase2 study for metastatic melanoma is actively seeking new participants at 1 location across the United States. The study is sponsored by National Cancer Institute (NCI). This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05155033 is actively recruiting participants as of October 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05155033 was last updated 5 days ago (October 8, 2026). HelloStudys verifies this status automatically.